News - WHA Response to the Cochrane Systematic Review on DAA-Based Treatment of Chronic Hepatitis C

The members of the Executive Board of the World Hepatitis Alliance (WHA) have written an open letter to the Cochrane Collaboration in which they raise doubts about the recent Cochrane review of direct-acting antivirals (DAAs) for the treatment of hepatitis C. The WHA points to the unsound methodology leading to unreliable conclusions.